Adhesion prevention with shear-thinning polymeric hydrogels

US11969526B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11969526-B2
Application numberUS-201815943358-A
CountryUS
Kind codeB2
Filing dateApr 2, 2018
Priority dateApr 3, 2017
Publication dateApr 30, 2024
Grant dateApr 30, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A tissue adhesion prevention hydrogel is provided and engineered with essential features for maintaining separation between tissues and organs in any part of the body, thus preventing adhesion formation, are their shear-thinning, viscoelasticity, and rapid self-healing. A method of using the tissue adhesion prevention hydrogel for tissue adhesion prevention is also provided. A method of interposing the tissue adhesion prevention in between tissue layers for tissue adhesion prevention is further provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising: interposing a dynamically cross-linked supramolecular hydrogel between two animal tissue layers, the dynamically cross-linked supramolecular hydrogel comprising non-covalent interactions between nanoparticles and a hydrophobically modified cellulose derivative; and preventing formation of tissue adhesion between the two animal tissue layers with the interposed dynamically cross-linked supramolecular hydrogel. 2. The method of claim 1 , wherein the cellulose derivative is hydroxypropylmethylcellulose (HPMC). 3. The method of claim 1 , wherein the nanoparticles are poly(ethyleneglycol)-block-poly(lacticacid) (PEG-PLA) nanoparticles. 4. The method of claim 1 , wherein the dynamically cross-linked supramolecular hydrogel is formed by combining a first aqueous solution that includes three percent weight by volume of the cellulose derivative and a second aqueous solution that includes fifteen percent weight by volume of the nanoparticles, the first and second aqueous solutions being combined in a 1:2 ratio by volume so that a final composition of the dynamically cross-linked supramolecular hydrogel is one percent weight by volume of the cellulose derivative and ten percent weight by volume of the nanoparticles. 5. The method of claim 1 , wherein the dynamically cross-linked supramolecular hydrogel is shear-thinning. 6. The method of claim 1 , wherein the dynamically cross-linked supramolecular hydrogel is self-healing. 7. The method of claim 1 , wherein the dynamically cross-linked supramolecular hydrogel includes polymer chains and non-covalent cross-linking bonds between at least some of the polymer chains. 8. The method of claim 7 , wherein the dynamically cross-linked supramolecular hydrogel is shear-thinning and the shear-thinning of the dynamically cross-linked supramolecular hydrogel is achieved via dissociation of at least some of the non-covalent cross-linking bonds between the non-covalently cross-linked polymer chains. 9. The method of claim 7 , wherein the dynamically cross-linked supramolecular hydrogel is self-healing and the self-healing of the dynamically cross-linked supramolecular hydrogel is achieved via reestablishment of the non-covalent cross-linking bonds between at least some of the non-covalently cross-linked polymer chains. 10. The method of claim 1 , wherein the dynamically cross-linked supramolecular hydrogel further comprises tissue adhesive polymers that act to adhere the dynamically cross-linked supramolecular hydrogel to the two animal tissue layers. 11. The method of claim 1 , wherein the two animal tissue layers are internal to a body of an animal. 12. The method of claim 1 , wherein the interposing comprises spraying the dynamically cross-linked supramolecular hydrogel between the two animal tissue layers. 13. The method of claim 1 , wherein the interposing comprises injecting the dynamically cross-linked supramolecular hydrogel between the two animal tissue layers. 14. A method comprising: interposing a dynamically cross-linked supramolecular hydrogel between two animal tissue layers to prevent formation of tissue adhesion between the two animal tissue layers, the dynamically cross-linked supramolecular hydrogel being from one to two percent weight by volume hydrophobically modified cellulose derivative, and from five to ten percent weight by volume nanoparticles, wherein the nanoparticles non-covalently interact with the hydrophobically modified cellulose derivative. 15. The method of claim 14 , wherein the dynamically cross-linked supramolecular hydrogel includes polymer chains and non-covalent cross-linking bonds between at least some of the polymer chains. 16. The method of claim 15 , wherein the dynamically cross-linked supramolecular hydrogel is shear-thinning and the shear-thinning of the dynamically cross-linked supramolecular hydrogel is achieved via dissociation of at least some of the non-covalent cross-linking bonds between the non-covalently cross-linked polymer chains. 17. The method of claim 15 , wherein the dynamically cross-linked supramolecular hydrogel is self-healing and the self-healing of the dynamically cross-linked supramolecular hydrogel is achieved via reestablishment of the non-covalent cross-linking bonds between at least some of the non-covalently cross-linked polymer chains. 18. The method of claim 14 , wherein the interposing comprises spraying the dynamically cross-linked supramolecular hydrogel between the two animal tissue layers. 19. The method of claim 14 , wherein the interposing comprises injecting the dynamically cross-linked supramolecular hydrogel between the two animal tissue layers. 20. The method of claim 1 , wherein the hydrophobically modified cellulose derivative is a cellulose derivative modified with a hydrophobic saturated or unsaturated alkyl moiety, or with a hydrophobic aryl moiety. 21. The method of claim 14 , wherein the hydrophobically modified cellulose derivative is a cellulose derivative modified with a hydrophobic saturated or unsaturated alkyl moiety, or with a hydrophobic aryl moiety.

Assignees

Inventors

Classifications

  • A61L31/041Primary

    Mixtures of macromolecular compounds · CPC title

  • Polysaccharides · CPC title

  • obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title

  • Hydrogels or hydrocolloids · CPC title

  • Anti-adhesion agents · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11969526B2 cover?
A tissue adhesion prevention hydrogel is provided and engineered with essential features for maintaining separation between tissues and organs in any part of the body, thus preventing adhesion formation, are their shear-thinning, viscoelasticity, and rapid self-healing. A method of using the tissue adhesion prevention hydrogel for tissue adhesion prevention is also provided. A method of interpo…
Who is the assignee on this patent?
Univ Leland Stanford Junior
What technology area does this patent fall under?
Primary CPC classification A61L31/041. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).